UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

Neurology, 2009-08, Vol.73 (5), p.342-348

2009

Volltextzugriff (PDF)

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

Neurology, 2012-02, Vol.78 (7), p.485-492

2012

Volltextzugriff (PDF)

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection

Molecular neurobiology, 2019-05, Vol.56 (5), p.3808-3818

2019

Volltextzugriff (PDF)

Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy

Journal of Virology, 2005-02, Vol.79 (3), p.1772-1788

2005

Volltextzugriff (PDF)

Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy

Pain (Amsterdam), 2010-12, Vol.151 (3), p.732-736

2010

Volltextzugriff (PDF)

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Neurology, 2010-12, Vol.75 (23), p.2087-2096

2010

Volltextzugriff (PDF)

Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort

Journal of acquired immune deficiency syndromes (1999), 2013-01, Vol.62 (1), p.36-42

2013

Volltextzugriff (PDF)

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

Journal of neurovirology, 2013-04, Vol.19 (2), p.150-156

2013

Volltextzugriff (PDF)

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

Neurology, 2000-02, Vol.54 (4), p.927-936

2000

Volltextzugriff (PDF)

Neurocognitive impairment in HIV-infected individuals with previous syphilis

International journal of STD & AIDS, 2013-05, Vol.24 (5), p.351-355

2013

Volltextzugriff (PDF)

Brain morphometric correlates of metabolic variables in HIV: the CHARTER study

Journal of neurovirology, 2014-12, Vol.20 (6), p.603-611

2014

Volltextzugriff (PDF)

Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment

Virology (New York, N.Y.), 2012-11, Vol.433 (2), p.498-505

2012

Volltextzugriff (PDF)

Cytomegalovirus Infections of the Nervous System in Patients with AIDS

Clinical infectious diseases, 1995-04, Vol.20 (4), p.747-754

McCutchan, J. Allen

1995

Volltextzugriff (PDF)

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era

The Journal of infectious diseases, 2016-04, Vol.213 (7), p.1065-1073

2016

Volltextzugriff (PDF)

Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study

Clinical infectious diseases, 2015-02, Vol.60 (3), p.473-480

2015

Volltextzugriff (PDF)

Cerebrospinal Fluid β Chemokine Concentrations in Neurocognitively Impaired Individuals Infected with Human Immunodeficiency Virus Type 1

The Journal of infectious diseases, 1999-08, Vol.180 (2), p.310-319

1999

Volltextzugriff (PDF)

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

AIDS (London), 2011-09, Vol.25 (14), p.1747-1751

2011

Volltextzugriff (PDF)

AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy

AIDS (London), 2001-09, Vol.15 (14), p.1898-1899

2001

Volltextzugriff (PDF)

Transforming Growth Factor β and Noncytopathic Mechanisms of Immunodeficiency in Human Immunodeficiency Virus Infection

Proceedings of the National Academy of Sciences - PNAS, 1990-11, Vol.87 (21), p.8321-8325

1990

Volltextzugriff (PDF)

Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging

Annals of internal medicine, 1987-12, Vol.107 (6), p.828

1987

Volltextzugriff (PDF)

Fluconazole Combined with Flucytosine for Treatment of Cryptococcal Meningitis in Patients with AIDS

Clinical infectious diseases, 1994-10, Vol.19 (4), p.741-745

1994

Volltextzugriff (PDF)

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response

AIDS (London), 1999-06, Vol.13 (9), p.1099-1107

1999

Volltextzugriff (PDF)

A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus

The Journal of infectious diseases, 1993-12, Vol.168 (6), p.1374-1379

1993

Volltextzugriff (PDF)

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy

The Journal of infectious diseases, 2017-01, Vol.215 (1), p.105-113

2017

Volltextzugriff (PDF)

1 – 25 von 1.132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(928)
Mit Volltextzugriff
(922)

Publikationsform

Sprache

Englisch
(1.130)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(661)
Life Sciences & Biomedicine
(540)
Humans
(519)
Male
(366)
Biological And Medical Sciences
(335)
Infectious Diseases
(312)
Adult
(309)
Female
(308)
Medical Sciences
(277)
Middle Aged
(229)
Aids/hiv
(227)
Human Immunodeficiency Virus
(222)
Immunology
(214)
Hiv
(191)
Virology
(170)
Viral Diseases
(154)
Human Viral Diseases
(151)
Microbiology
(133)
Neurosciences & Neurology
(130)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(130)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection

Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy

Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

Neurocognitive impairment in HIV-infected individuals with previous syphilis

Brain morphometric correlates of metabolic variables in HIV: the CHARTER study

Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment

Cytomegalovirus Infections of the Nervous System in Patients with AIDS

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era

Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study

Cerebrospinal Fluid β Chemokine Concentrations in Neurocognitively Impaired Individuals Infected with Human Immunodeficiency Virus Type 1

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy

Transforming Growth Factor β and Noncytopathic Mechanisms of Immunodeficiency in Human Immunodeficiency Virus Infection

Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

Fluconazole Combined with Flucytosine for Treatment of Cryptococcal Meningitis in Patients with AIDS

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response

A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy

Suchergebnisse filtern